Custom service

Peptides-Fatty Acids Conjugation

Lipidate peptides with myristate, palmitate or bespoke fatty-acid chains for half-life extension

Turnaround: 4–6 weeksTypical scale: 0.1–50 mg conjugate per batchChemistry options: side-chain lipidation at Lys, Cys or the N-terminus; Fmoc solid-phase lipidation; albumin-binding motif integration

Peptides-Fatty Acids Conjugation supports programmes that lipidate peptides with myristate, palmitate or bespoke fatty-acid chains for half-life extension. In a typical engagement we plan the side-chain lipidation at Lys, Cys or the N-terminus route first, confirm compatibility with Fmoc solid-phase lipidation, and release lipidated peptide with purity and lipid-ratio QC on a 4–6 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep side-chain lipidation at Lys, Cys or the N-terminus as the primary option and hold Fmoc solid-phase lipidation in reserve, so that scale-up never depends on an unproven step.

GLP-1-class half-life extension programmes

Albumin-binding therapeutic concepts

Sterile injectable presentation of the final lipidated peptide

Conjugates whose payload cannot tolerate aqueous coupling conditions

Every conjugation batch is documented from vial to vial: carrier lot, payload lot, reagent lots, reaction conditions and purification chromatograms. The release package contains the loading ratio measured by an orthogonal method (UV, ICP-MS or amino-acid analysis), identity by mass spectrometry where the conjugate permits it, and residual-free-payload data.

Service Highlights

  • Side-chain lipidation at Lys, Cys or the N-terminus as the default route, with Fmoc solid-phase lipidation held as a proven fallback
  • Albumin-binding motif integration worked into the design where the application requires it
  • Carrier and payload compatibility screened in a small feasibility batch before full material is committed
  • Analytical confirmation of every intermediate before the final release
  • Unreacted payload driven below the detection limit of the release assay before purification is closed
  • Lipidated peptide with purity and lipid-ratio QC delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Scope & design

    We review the payload, the carrier and the intended assay or study, and propose between side-chain lipidation at Lys, Cys or the N-terminus and Fmoc solid-phase lipidation as candidate routes.

  2. Feasibility screen

    A milligram-scale screen compares loading, residual payload and activity across the candidate conditions.

  3. Production conjugation

    The selected condition is executed at project scale with in-process sampling at fixed time points.

  4. Purification

    Size-exclusion, dialysis or magnetic separation removes free payload and by-products.

  5. Characterization & release

    Identity, loading ratio and functional activity are measured against the agreed specification.

  6. Documentation & hand-off

    Lipidated peptide with purity and lipid-ratio QC is packaged with the full batch record, released for shipment after QC sign-off.

Specifications & timeline

Turnaround
4–6 weeks
Typical scale
0.1–50 mg conjugate per batch
Chemistry options
side-chain lipidation at Lys, Cys or the N-terminus; Fmoc solid-phase lipidation; albumin-binding motif integration
Deliverable
Lipidated peptide with purity and lipid-ratio QC
QC package
HPLC/SEC trace, MALDI-TOF or ESI-MS, UV/Vis or ICP-MS loading ratio
Shipping
Blue ice or dry ice as the payload requires, with a cold-chain manifest

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.